Design, synthesis, biological evaluation and in silico studies of few novel 2-substituted benzothiazole derivatives as potential egfr inhibitors

Mubeen, Muhammad and Kini, Suvarna G and Kumar, Avinash and Pai, Sreedhara Ranganath K (2019) Design, synthesis, biological evaluation and in silico studies of few novel 2-substituted benzothiazole derivatives as potential egfr inhibitors. Letters in Drug Design & Discovery, 16 (8). pp. 961-971. ISSN 1570-1808

[img] PDF
00007186.pdf - Published Version
Restricted to Registered users only

Download (1MB) | Request a copy

Abstract

Background: There is a great unmet medical need for new anticancer small molecule therapeutics. Exhaustive literature review suggests that benzothiazole derivatives have good potential to exhibit anticancer activity. Compounds that inhibit the kinase activity of EGFR are of potential interest as new antitumor agent. Objective: To design, synthesize and carry out in silico along with biological evaluation of 2- substituted benzothiazole compounds with EGFR inhibitory activity. Methods: Benzothiazole derivatives designed from molecular docking method for potential EGFR tyrosine kinase inhibition have been synthesized based on the docking results and characterized. Insilico studies were carried out to understand the mode of EGFR enzyme inhibition by our molecules. As a preliminary study, these compounds were first screened for antioxidant activity and then for anticancer activity against MCF-7 cell lines and A549 cell line. Results: Compound B5 showed potent anticancer activity on MCF-7 cell line with IC50 value of 9.7μM and compound B8 showed significant anticancer activity on A549 cell line with IC50 value of 49.7μM in comparison with the standard drug Doxorubicin (IC50 = 1.4μM on MCF-7 and 1.0μM on A549 cell lines). In EGFR inhibitory activity B8 showed maximum activity on A549 cell line by inactivating 69.10% of EGFR phosphorylation and B7 showed maximum activity on MCF-7 cell line by inactivating 41.90% of EGFR phosphorylation in comparison with the reference drug Gefitinib. Molecular dynamics simulation studies suggest that benzothiazole derivative could also bind to allosteric site and inhibit the EGFR enzyme activity. Conclusion: Reported compounds have shown potent anticancer activity through EGFR inhibition by possibly binding at allosteric site.

Item Type: Article
Uncontrolled Keywords: Benzothiazole; synthesis; docking; antioxidant; anticancer; EGFR; breast cancer; MCF-7.
Subjects: Pharmacy > MCOPS Manipal > Pharmaceutical Chemistry
Pharmacy > MCOPS Manipal > Pharmacology
Depositing User: KMC Library
Date Deposited: 23 Aug 2019 06:46
Last Modified: 23 Aug 2019 06:46
URI: http://eprints.manipal.edu/id/eprint/154432

Actions (login required)

View Item View Item